Copyright © DrugPatentWatch. Originally published at New patent for Optinose Us drug XHANCE
Annual Drug Patent Expirations for XHANCE
Xhance is a drug marketed by Optinose Us Inc and is included in one NDA. There are sixteen patents protecting this drug.
This drug has two hundred and forty-five patent family members in twenty-eight countries.
The generic ingredient in XHANCE is fluticasone propionate. Additional details are available on the fluticasone propionate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
Copyright © DrugPatentWatch. Originally published at New patent for Optinose Us drug XHANCE
Related
Source: https://www.drugpatentwatch.com/blog/new-patent-for-optinose-us-drug-xhance/
